Click HERE to access the handout
If you are a speech-language pathologist and would like to receive a certificate and/or earn ASHA CEUs after viewing this On-Demand webinar, please follow the below steps:
- View the webinar in its entirety.
- Complete the LSVT LOUD On Demand Webinar Survey 2023.
- If you request a certificate, LSVT Global will verify your viewing of the webinar and email you a certificate within two weeks.
- If you would like LSVT Global to report your course completion to the ASHA CE Registry, we will submit a report after December 31, 2023. See note below for more information.
NOTE: LSVT LOUD On Demand webinars are registered for ASHA CEUs as one course through the end of 2023. The last day for viewing the webinars and completing the surveys is December 31, 2023. The report will be submitted after December 31, 2023 and it can take several weeks to appear on your ASHA Registry. We are not allowed to submit your CEUs for this course prior to December 31, 2023. The report will indicate the year viewed as 2023, even though it will be posted to your registry after December 31, 2023.
The impact of dysarthria secondary to stroke, traumatic brain injury (TBI), and other neuro cases can be significant and can affect a person’s ability to communicate effectively, leading to social isolation and reduced quality of life.
In this webinar, we will focus on the use of LSVT LOUD for the management of dysarthria secondary to stroke and TBI.
The webinar will cover the following topics:
- Overview of dysarthria secondary to stroke and TBI
- How principles of LSVT LOUD treatment apply to dysarthria secondary to stroke, TBI, and other neuro cases
- Case studies illustrating the use of LSVT LOUD as part of stroke and TBI rehabilitation
- Strategies and considerations for incorporating LSVT LOUD post-stroke, TBI, and other neuro cases
Tune in to learn how LSVT LOUD can help individuals with dysarthria secondary to neural injury beyond Parkinson’s communicate more effectively and improve their overall quality of life.
Intended Audience: Speech-language pathologists